Choriocapillaris vascular dropout related to density of drusen in human eyes with early age-related macular degeneration.

PURPOSE Age-related macular degeneration (AMD) is a common, potentially blinding disease characterized by the presence of extracellular deposits beneath the retinal pigment epithelium (RPE). Choroidal vascular changes have also been noted in AMD. This study examined the relationship between the choroidal vasculature and extent of drusen and other sub-RPE deposits, the key pathologic landmarks of AMD. METHODS Sections of the maculas of 45 human eyes (21 early AMD and 24 age-matched control) were evaluated morphometrically. The cross-sectional area of sub-RPE deposits, vascular density, number of CD45+ leukocytes, and number of "ghost vessels" were determined in a masked fashion and evaluated by regression analysis. In addition, the extramacular vascular density either directly beneath drusen or adjacent to drusen was evaluated in a separate set of donor eyes. RESULTS The vascular density of the choriocapillaris showed a trend toward decreasing in association with AMD status. By linear regression analysis, vascular density was inversely associated with sub-RPE deposit density (r(2) = 0.22, P < 0.01). The number of ghost vessels was negatively correlated with vascular density (r(2) = 0.55, P < 0.001) and positively correlated with sub-RPE deposit density (r(2) = 0.57, P < 0.001). In morphologic studies of extramacular solitary drusen, vascular density beneath drusen was found to be 45% lower than adjacent to drusen (P < 0.01). CONCLUSIONS These findings support the concept that microvascular changes are related to the pathogenesis of AMD and suggest that vascular endothelial cell loss occurs in association with sub-RPE deposit formation. Whether microvascular events are a cause or consequence of drusen or other deposit formation remains to be determined.

[1]  A. Miettinen,et al.  Ulex europaeus I lectin as a marker for tumors derived from endothelial cells. , 1983, American journal of clinical pathology.

[2]  R. T. Smith,et al.  A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3]  P. D. de Jong,et al.  Early stages of age-related macular degeneration: an immunofluorescence and electron microscopy study. , 1993, The British journal of ophthalmology.

[4]  T KUWABARA,et al.  Senile choroidal vascular patterns and drusen. , 1963, Archives of ophthalmology.

[5]  J D Gass,et al.  Drusen and disciform macular detachment and degeneration. , 1973, A M A Archives of Ophthalmology.

[6]  B. Feigl Age-related maculopathy – Linking aetiology and pathophysiological changes to the ischaemia hypothesis , 2008, Progress in Retinal and Eye Research.

[7]  L. V. Johnson,et al.  Accumulation of extracellular RGR-d in Bruch's membrane and close association with drusen at intercapillary regions. , 2009, Experimental eye research.

[8]  N. Bressler,et al.  Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration. 1994. , 2005, Retina.

[9]  C. Curcio,et al.  Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy. , 2003, The American journal of pathology.

[10]  C. Reilly,et al.  Proteomics of the retinal pigment epithelium reveals altered protein expression at progressive stages of age-related macular degeneration. , 2006, Investigative ophthalmology & visual science.

[11]  R. Mullins Genetic Insights Into the Pathobiology of Age-related Macular Degeneration , 2007, International ophthalmology clinics.

[12]  Jennifer I. Lim,et al.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.

[13]  R. Klein,et al.  The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study. , 1997, Ophthalmology.

[14]  H. Grossniklaus,et al.  Histologic and morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in postmortem eyes with age-related macular degeneration and histologic examination of surgically excised choroidal neovascular membranes. , 1999, Survey of ophthalmology.

[15]  A. Ho,et al.  Foveolar choroidal blood flow in age-related macular degeneration. , 1998, Investigative ophthalmology & visual science.

[16]  K. Nakashima,et al.  [The Rotterdam study]. , 2011, Nihon rinsho. Japanese journal of clinical medicine.

[17]  R. Mullins,et al.  Glycoconjugates of choroidal neovascular membranes in age-related macular degeneration. , 2005, Molecular vision.

[18]  P. Raymond,et al.  Improved method for obtaining 3-microns cryosections for immunocytochemistry. , 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[19]  A C Bird,et al.  Drusen as risk factors in age-related macular disease. , 1990, American journal of ophthalmology.

[20]  Ching-Yu Cheng,et al.  Pulsatile ocular blood flow in asymmetric exudative age related macular degeneration , 2001, The British journal of ophthalmology.

[21]  J D Gottsch,et al.  Oxidative damage and age-related macular degeneration. , 1999, Molecular vision.

[22]  E. Stone A very effective treatment for neovascular macular degeneration. , 2006, The New England journal of medicine.

[23]  G. Lip,et al.  Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction. , 2001, Ophthalmology.

[24]  Takayuki Baba,et al.  Relationship between RPE and choriocapillaris in age-related macular degeneration. , 2009, Investigative ophthalmology & visual science.

[25]  Marco A Zarbin,et al.  PATHWAY-BASED THERAPIES FOR AGE-RELATED MACULAR DEGENERATION: An Integrated Survey of Emerging Treatment Alternatives , 2010, Retina.

[26]  Masaru Miyagi,et al.  Drusen proteome analysis: An approach to the etiology of age-related macular degeneration , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Christine A. Curcio,et al.  Abundant Lipid and Protein Components of Drusen , 2010, PloS one.

[28]  B. Godley,et al.  Mitochondrial DNA damage and its potential role in retinal degeneration , 2008, Progress in Retinal and Eye Research.

[29]  W. Green,et al.  IRON TOXICITY AS A POTENTIAL FACTOR IN AMD , 2007, Retina.

[30]  P T de Jong,et al.  Morphometric analysis of Bruch's membrane, the choriocapillaris, and the choroid in aging. , 1994, Investigative ophthalmology & visual science.

[31]  C. Curcio,et al.  Basal linear deposit and large drusen are specific for early age-related maculopathy. , 1999, Archives of ophthalmology.

[32]  S. Russell,et al.  Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells. , 2010, Investigative ophthalmology & visual science.

[33]  Alston Callahan,et al.  The role of inflammation in the pathogenesis of age-related macular degeneration. , 2006, Survey of ophthalmology.

[34]  H. Grossniklaus,et al.  Morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in eyes with age-related macular degeneration. , 1996, Investigative ophthalmology & visual science.

[35]  R. Mullins,et al.  Macular and peripheral distribution of ICAM-1 in the human choriocapillaris and retina. , 2006, Molecular vision.

[36]  S. Russell,et al.  Drusen associated with aging and age‐related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  E S Gragoudas,et al.  Ocular blood flow velocity in age-related macular degeneration. , 1995, Ophthalmology.

[38]  P. Penfold,et al.  Senile macular degeneration: The involvement of immunocompetent cells , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[39]  D. S. Mcleod,et al.  Phosphatase enzyme histochemistry for studying vascular hierarchy, pathology, and endothelial cell dysfunction in retina and choroid , 2005, Vision Research.

[40]  Sonia H Yoo,et al.  Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. , 2003, Survey of ophthalmology.

[41]  Chi-Chao Chan,et al.  Molecular pathology of age-related macular degeneration , 2009, Progress in Retinal and Eye Research.

[42]  Johanna M Seddon,et al.  The genetics of age-related macular degeneration: a review of progress to date. , 2006, Survey of ophthalmology.

[43]  J L McRae,et al.  Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease) , 2005, Journal of Medical Genetics.

[44]  J. Matsubara,et al.  Complement-associated deposits in the human retina. , 2008, Investigative ophthalmology & visual science.

[45]  G. Ying,et al.  Association of risk factors for choroidal neovascularization in age-related macular degeneration with decreased foveolar choroidal circulation. , 2010, American journal of ophthalmology.

[46]  S. Sarks,et al.  Ageing and degeneration in the macular region: a clinico-pathological study. , 1976, The British journal of ophthalmology.

[47]  M. Killingsworth,et al.  Early drusen formation in the normal and aging eye and their relation to age related maculopathy: a clinicopathological study , 1999, The British journal of ophthalmology.

[48]  A. Bird,et al.  Association of drusen deposition with choroidal intercapillary pillars in the aging human eye. , 2004, Investigative ophthalmology & visual science.

[49]  A C Bird,et al.  A fluorescein and indocyanine green angiographic study of choriocapillaris in age-related macular disease. , 1999, Archives of ophthalmology.

[50]  Marco A Zarbin,et al.  Current concepts in the pathogenesis of age-related macular degeneration. , 2004, Archives of ophthalmology.

[51]  L. V. Johnson,et al.  A potential role for immune complex pathogenesis in drusen formation. , 2000, Experimental eye research.

[52]  Robert F Mullins,et al.  A role for local inflammation in the formation of drusen in the aging eye. , 2002, American journal of ophthalmology.

[53]  M L Bots,et al.  Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. , 1995, American journal of epidemiology.

[54]  T. Hikichi,et al.  Pulsatile ocular blood flow study: decreases in exudative age related macular degeneration , 2001, The British journal of ophthalmology.

[55]  M. C. Leske,et al.  Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group. , 2000, Archives of ophthalmology.

[56]  T. Amemiya,et al.  Natural Course of Experimental Choroidal Neovascularization: Three-Dimensional Study with Corrosion Cast and Scanning Electron Microscope , 2002, Ophthalmic Research.

[57]  S. Vuk-Pavlović,et al.  Immune cells in the human choroid , 2008, British Journal of Ophthalmology.

[58]  M. Zarbin,et al.  Age-Related Macular Degeneration: Review of Pathogenesis , 1998, European journal of ophthalmology.

[59]  Magali Saint-Geniez,et al.  An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris , 2009, Proceedings of the National Academy of Sciences.